Skip to main content
Clinical Trials/NL-OMON28558
NL-OMON28558Not yet recruitingNot Applicable

Repeated measurements in patients presenting with ST-segment elevation myocardial infarction of Advanced Glycation Endproducts by skin autofluorescence and serum analysis: A pilot study (STAGE study).

Erasmus Medical Center, RotterdamProf. Eric Boersma, MSc, PhD, FESC, Professor of clinical epidemiology of cardiovascular diseases.0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

/A

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • The following inclusion criteria will be applied (all criteria should apply):
  • 1. Men and women, aged from 18 to 70 years, capable of understanding the study content of and willing to provide written informed consent at admission to the hospital;

Exclusion Criteria

  • Patients with at least one of the following characteristics will be excluded:
  • 1. Myocardial ischemia precipitated by a condition other than atherosclerotic coronary artery disease;

Investigators

Sponsor
Erasmus Medical Center, RotterdamProf. Eric Boersma, MSc, PhD, FESC, Professor of clinical epidemiology of cardiovascular diseases.

Similar Trials